Medicare Revenue Report Card 2026
Hematology/Oncology
4K providers nationally
One-Click LinkedIn Post
I just reviewed the 2026 Medicare Revenue Report Card for Hematology/Oncology. Key findings: - Overall Grade: F - Estimated Missed Revenue: $248.4M - Low adoption of care management programs (CCM, RPM, BHI, AWV) The data comes directly from CMS public records — every medical practice can see exactly how much revenue they're leaving on the table. See the full Hematology/Oncology report card:
https://npixray.com/reports/specialties/hematology-oncology
Provider Count
4K
Avg Medicare Patients
152
Avg Total Payment
$235K
Est. Missed Revenue
$248.4M
across all providers
Care Management Program Adoption
Adoption rates for revenue-generating care management programs among Hematology/Oncology providers compared to national averages.
CCM
Chronic Care Management
$62/patient/mo potential revenue
RPM
Remote Patient Monitoring
$120/patient/mo potential revenue
BHI
Behavioral Health Integration
$50/patient/mo potential revenue
AWV
Annual Wellness Visits
$175/visit potential revenue
Hematology/Oncology Trend Signals
Hematology/Oncology Revenue
$235K
+102.1% vs benchmark · national avg $116K
CCM Adoption
0.0%
-100.0% vs benchmark · national 2.4%
RPM Adoption
0.0%
-100.0% vs benchmark · national 1.1%
E&M Coding Distribution
How Hematology/Oncology providers distribute their E&M visits across complexity levels versus the specialty benchmark.
99213
Level 3
0.0%
Benchmark: 20.0%
99214
Level 4
0.0%
Benchmark: 54.0%
99215
Level 5
0.0%
Benchmark: 24.5%
Key Revenue Metrics
$2K
Avg Revenue per Patient
152
Avg Medicare Patients
17K
Avg Services per Provider
Scan a Provider in Hematology/Oncology
Scan Any Provider's Revenue
Enter any NPI number to instantly see missed revenue from E&M coding gaps, CCM, RPM, BHI, and AWV programs.
Run Free Scan